thiazoles has been researched along with Pleural Effusion, Malignant in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbruzzi, A; Bromberg, J; Chang, J; D'Andrea, G; Dang, C; Dickler, M; Fornier, MN; Gilewski, T; Hudis, CA; Modi, S; Morris, PG; Norton, L; Seidman, AD; Sklarin, N | 1 |
Nakashima, S; Tanaka, H; Usuda, M | 1 |
Apperley, JF; Bua, M; Chaidos, A; de Lavallade, H; Gabriel, IH; Goldman, JM; Khorashad, JS; Marin, D; Milojkovic, D; Olavarria, E; Punnialingam, S | 1 |
1 trial(s) available for thiazoles and Pleural Effusion, Malignant
Article | Year |
---|---|
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Dasatinib; Edema; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pleural Effusion, Malignant; Pyrimidines; Thiazoles; Treatment Outcome | 2011 |
2 other study(ies) available for thiazoles and Pleural Effusion, Malignant
Article | Year |
---|---|
Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cytomegalovirus; Dasatinib; Female; Gene Rearrangement, T-Lymphocyte; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes, Mononuclear; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pleural Effusion, Malignant; Protein Kinase Inhibitors; Pyrimidines; Receptors, Antigen, T-Cell; Thiazoles; Treatment Outcome; Virus Activation; Young Adult | 2012 |
Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis.
Topics: Adult; Aged; Antineoplastic Agents; Autoimmune Diseases; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Pleural Effusion, Malignant; Pyrimidines; Retrospective Studies; Thiazoles | 2008 |